Researchers analyzed recent trends in cervical cancer incidence and mortality and made predictions for the next 15 years.
An update on the available cancer screening guidelines, benefits/limitations, and risks for cervical, breast, prostate, colon, and lung cancers.
Among patients with a higher risk of metastasis, sentinel lymph node mapping had a sensitivity of 96.3%.
Genetic variations in the PAX8, CLPTM1L, and HLA genes were found to be associated with a high risk of developing cervical cancer.
A minority of women met criteria to exit cervical cancer screening.